Wyniki wyszukiwania - BazTech

1

2,2’-dihydroksy-1,1’-binaftyl (BINOL) i jego pochodne. Wybrane syntezy i zastosowanie. Część. II

Krasowska D.

Wiadomości Chemiczne

|

2013

|

[Z] 67, 1-2

55--92

EN

An invention of new catalytic strategies for stereoselective synthesis is of current interest to many laboratories worldwide . Over the past few decades a remark - able progress in the field of stereocontrolled synthesis has been achieved with chiral 1,1’-binaphthyl compounds. Optically active 1,1’-binaphthyl-2,2’-diol (BINOL) and its derivatives due to their axial dissymmetry and molecular flexibility have been widely utilized as chiral ligands and auxiliaries in stoichiometric or catalytic asymmetric reactions, such as metal-catalysed transformations and enantioselective organocatalysis. BINOL and its functionalized analogues have demonstrated remark - able chiral discrimination properties. Extensive studies on molecular recognition provided the successful results in the application of BINOL as a host for an optical resolution of racemic guests and as a chiral NMR shift reagent for the determination of chiral compounds. It has been found that the axial chirality of binaphthyl units in host molecules is crucial contribution to their stereoselctive complexation with chiral guests.

2

2,2'- Dihydroksy-1,1'-binaftyl (BINOL ) i jego pochodne. Wybrane syntezy i zastosowanie. Część I

Krasowska D.

Wiadomości Chemiczne

|

2012

|

[Z] 66, 5-6

485-528

EN

1,1’-Binaphthyl and its derivatives represent a particular class of chemical molecules which chirality results from the restricted rotation about single bond of the two naphthalene rings. This generates the chirality axis. Therefore 1,1’-binaphthyl derivatives exist as two enantiomeric forms called atropoisomers. Moreover, 1,1’- binaphthyls with substituents at 2,2’ position exhibit higher rotational barriers around the 1,1’-axis, which affect a very stable chiral configuration. The classical examples of such molecules is 2,2-dihydroxy-1,1’-binaphthyl (BINOL ), which has become one of the most utilized chiral ligand and auxiliary for diverse asymmetric syntheses. The unchallenged success of BINOL and its derivatives in the field of transition metal-catalyzed asymmetric reactions or C-C bond forming reactions promoted worldwide an advancement of organic synthesis. The first synthesis of BINOL as racemate was described in 1873. Since then there have been found numerous efficient methods of racemic or enantiomerically pure BINOL preparation and its derivatization. In order to present a brief overview of the most convenient and facile routes to obtain racemic and nonracemic symmetrically substituted 1,1’-binaphthyls based on stoichiometric and catalytic oxidative coupling, classical optical resolution, kinetic enzymatic resolution of racemic mixture or regioselective modification of the binaphthol scaffold the following article is presented.

3

Leki przeciw grypie. Synteza tamiflu® - leku gromadzonego, aby zapobiec epidemii ptasiej grypy

Karchier M., Michalak K., Wicha J.

Wiadomości Chemiczne

|

2007

|

[Z] 61, 1-2

7-42

EN

Influenza (flu) and related viral infections present a constant threat to public health. World-wide efforts have been recently initiated (coordinated by WHO) to prevent global epidemic in view of spreading deadly bird flu virus (H5N1) among people. Attention has been focused on Tamiflu® (1, Figure 1), synthetic, orally active drug manufactured by Hoffmann - La Roche On the surface of the flu virus there are located two proteins important for infecting animal cell: hemagglutinin and neuraminidase (sialidase). Hemagglutinin is responsible for the recognition of specific sialic acids in the cell membrane glycoconjugates; neuraminidase is involved in subsequent hydrolysis of sialic acid residue and is crucial for the virus propagation. Sialic acids are sugar-related keto-acids, as neuraminic acid 2. Their structure is specific for a given species. Functions of hemagglutinin or neuraminidase have been targeted in systematic search for anti-flu drugs. The first efficient neuraminidase competitive inhibitor Relanza® (Zanamivir) has been obtained as a mimic of hypothetic oxonium ion involved in sialic acid hydrolysis. Many structures related to Zanamivir have been investigated]. The most successful line of research has been aimed at synthesis of carbocyclic neuraminic acid derivatives from (-)-quinic or (-)-shikimic acids. The Gilead-Roche "first generation" analogue with the double bond oriented toward the hydroxy-group 33 proved more active than its counterpart 34. Further modification of the structure 33 was based on X-ray analysis of protein - inhibitor complexes and led to Tamiflu®. Prime synthesis of Tamiflu® from (-)-shikimic acid involved several steps. Since this starting material is rather expensive more economic approaches have been studied. The technological approach to the key epoxide 75 from (-)-quinic acid involves bicyclic lactone 70 controlled dehydration to form 73 and regiospecific acetal reduction using borane-dimethylsulfide complex in the presence of a silylating agent. Use of the developed methods and shikimic acid as the starting material allowed for an efficient access to the target epoxide 75. The epoxide 75 has been transformed into the final product in several steps. Most advanced synthetic routes transforming 75 into Tamiflu® rely upon the use of tert-butylamine and then diallylamine. Current studies on transformation of glucose into shikimic acid by genetically modified strain of Escherichia coli are likely to secure supplies of this convenient starting material for Tamiflu® production. E. J. Corey et al. have developed enantioselective total synthesis of Tamiflu®. [2+4] cycloaddition reaction of butadiene and trifluoroethylacrylate in the presence of a chiral oxazoborolidine catalyst provided cyclohex-3-enecarboxylic acid derivative (87, Scheme 19). Transformation of 87 into 99 embraced several steps, including the novel haloamidation (86 into 97). The synthesis route involved 12 steps and afforded Tamiflu® in 25% overall yield. Catalytic enantioselective reaction of the easily accessible meso-aziridine 101with trimethylsilylazide provided the cornerstone to total synthesis of Tamiflu® by M. Shibasaki et al. [48]. The synthetic route from azide 102 to the target involved several steps (Schemes 23 and 24). Among them the efficient allylic oxidation of 109 and the nickel-catalyzed conjugate addition of trimethylsilylcyanide to ?,?-unsaturated ketone 110 that contribute to general synthetic methodology. In the synthesis developed by Cong i Yao [51], the starting material - serine-derived aldehyde 117 (Garner's aldehyde, Scheme 25) has been selected from the "chiral pool". The synthesis involves a sequence of diastereoselective reactions and the ring-closure metathesis reaction (130 into 131) using the II generation Grubbs catalyst. Approaches to Tamiflu® illustrate the impressive achievements of organic synthesis. However, at present the high cost of this drug may hamper its broader application.